Merck CEO Says Co Will Focus On $1 Billion To $15 Billion "Sweet Spot" For M&A

Benzinga Newsdesk www.benzinga.com Neutral 93.1%

Neg 0% Neu 93.1% Pos 0%

- Goldman Sachs Healthcare Conference

Comments

No comments yet. Be the first!